Developer docs
API playgroundTry for free, no card

Search company profiles

The American Macular Degeneration Foundation

Full company profile

uuid000l8gz

Namestring
The American Macular Degeneration Foundation
Legal namestring
The American Macular Degeneration Foundation
Websiteurl
macular.org
Company typeenum
Private
Founded yearstring
-
Descriptiontext

The American Macular Degeneration Foundation (AMDF) is a 501(c)(3) publicly supported non-profit (Charity ID #04-3274007) headquartered in Northampton, Massachusetts, dedicated to the prevention, treatment, and cure of macular degeneration. The organization serves people living with age-related macular degeneration in all forms (dry AMD, wet AMD, geographic atrophy) as well as Stargardt disease, alongside caregivers and at-risk individuals. Its core "products" are educational resources (a website, videos, recipes, and the registered Feast for the Eyes® cookbook developed with AMD researcher Dr. Johanna Seddon), awareness assets (the AMD Awareness Pin, the "Losing Sight, Finding Hope" documentary), and research grants funded jointly with Research to Prevent Blindness, the International Retinal Research Foundation, and Fight for Sight — most notably the $300,000-per-grantee RPB/AMDF Catalyst Awards.

AMDF's business model is donation-driven rather than commercial. Revenue is sourced from individual donations (tax-deductible contributions), small-ticket donation products ($25 AMD Awareness Pin, $25 Hope & Cope DVD and quarterly newsletter, $100 Feast for the Eyes Calendar), grassroots fundraising events, and minor-tier corporate partnerships (Bananagrams, Tip-n-Split). The foundation supplements its direct donations by channeling funds through co-funded research grants, effectively leveraging partner foundations' grant-making infrastructure. Its go-to-market is community-led: content marketing via macular.org, YouTube, Facebook, email and print newsletters, plus advocacy campaigns such as the annual "AMDF Goes to Washington" event run jointly with NAEVR to influence federal AMD research funding and Medicare coverage for assistive devices.

The organization operates with a small team of 1–10 employees (described internally as a tight-knit group that shifted to remote work via Zoom during the COVID-19 pandemic) and is led by Founder and President Chip Goehring III, with Matthew Levine as Director of Grants, Partnerships, and Advocacy. AMDF has no parent company, no subsidiaries, and no disclosed revenue figure; it is independent and donor-funded. Recent milestones include the 2023 FDA approval of SYFOVRE — the first geographic atrophy treatment — which AMDF-supported research helped enable, the 2023 dosing of the first patient in Ocugen's gene therapy trial for advanced dry AMD, and ongoing Congressional advocacy for AMD patients through early 2026.

Short descriptiontext

The American Macular Degeneration Foundation is a 501(c)(3) non-profit based in Northampton, MA, that funds AMD research, delivers patient education and awareness resources, and advocates on macular degeneration policy for affected patients, caregivers, and at-risk individuals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNorthampton, United States
HQ citystring
Northampton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
macular degeneration research, vision loss support, retinal disease education, low vision resources, eye health advocacy
Industry1 code
1Non-Communicable Disease Prevention & Chronic Disease Programs
CodeBPAIAJAIPrimaryYes
NAICS code1 code
  • Religious, Grantmaking, Civic, Professional, and Similar Organizations813
Product category
Vision Health Nonprofit
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Donations and Contributions
TypeGrants Donations
Description

AMDF is a 501(c)(3) non-profit organization funded primarily through donations from individuals. Charity ID #04-3274007. Contributions are tax deductible to the extent allowed by law.

macular.org
2Research Grants and Partnerships
TypeProfessional Services
Description

Organization funds research grants through partnerships with other foundations including Research to Prevent Blindness and Fight for Sight, leveraging resources to accelerate AMD research.

macular.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details3 tiers
1AMD Awareness Pin - available at any donation level
ModelOtherBilling cadenceOne time
Notes

Suggested donation of $25 or more to help cover pin costs. $250+ underwrites other AMD education and awareness efforts and research.

macular.org
2Feast for the Eyes Calendar - gift with $100+ donation
ModelOtherBilling cadenceOne time
Notes

Available with $100 or more donation through December.

macular.org
3Hope & Cope DVD and quarterly newsletter
ModelOtherBilling cadenceOne time
Notes

Available for $25 contribution.

macular.org
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1AMD Awareness Pin
Description

Symbolic awareness pin designed to raise visibility for age-related macular degeneration, featuring eye shapes, orange dots representing AMD as third leading cause of blindness, blue iris for increased risk, starburst center representing central vision loss, and orange petals representing marigold as source of lutein and Zeaxanthin.

macular.org
Core offering1 text field

The American Macular Degeneration Foundation (AMDF) is a 501(c)(3) nonprofit organization that funds scientific research into the causes, prevention, and treatment of macular degeneration while providing patient and caregiver education, support resources, and advocacy for those affected by age-related macular degeneration (AMD) and related retinal diseases.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Funding breakthrough research leading to FDA approval of SYFOVRE, the first treatment for geographic atrophy (advanced dry AMD)
+1 more record
Product and service10 records
1AMD Awareness Pin
CategoryAwareness Merchandise
2Feast for the Eyes Calendar
CategoryEducational Resource
3Hope & Cope DVD
CategoryEducational Media
4KeepSight Journal
CategoryPatient Resource
5Amsler Grid
CategoryDiagnostic Resource
6In the Spotlight Newsletter
CategoryEducational Publication
7Eat Right for Your Sight Cookbook
CategoryEducational Resource
8Losing Sight, Finding Hope Documentary
CategoryAwareness Media
9Macular Degeneration Patient Research Registry
CategoryResearch Program
10AMDF Research Grants Program
CategoryResearch Funding
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AMDF partners with RPB to co-fund the RPB/AMDF Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration. Each grantee receives $300,000 across three years. RPB brings grant-making expertise and broad awareness among leading vision researchers, while AMDF contributes passionate commitment to AMD patients. The partnership more than doubles capacity to fund AMD research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IRRF is part of a broader collaboration co-funding AMD research grants alongside RPB and AMDF, supporting a total of four research grants in the Catalyst Awards program.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

AMDF extended its partnership with Fight for Sight to provide resources for postdoctoral scholars to conduct investigations and travel to the ARVO annual meeting to share concepts with mentors. Grants announced at ARVO.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AMDF works with NAEVR on advocacy efforts including AMDF Goes to Washington events. NAEVR staff including Dan Ignaszewski and Mikyla Bethune joined AMDF in Congressional office visits. Together they co-hosted a Congressional Briefing on macular degeneration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

The Vision & Art Project is an AMDF-supported project that chronicles the intersection between macular degeneration and the arts. AMDF supports this initiative to inspire and educate about living with vision loss through artistic expression.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Bananagrams partnered with AMDF to raise awareness about macular degeneration through the Big Letter Bananagrams game. Proceeds from the game are donated to AMDF, and the companies collaborated on the #BringBigSmiles campaign. AMDF traveled to Rhode Island to help kick off the launch.

7Tip-n-Split
Strategic tierMinorTypeGTM or Marketing Partner
Description

Tip-n-Split founder Connie Inukai gives 10% of proceeds from online sales to AMDF. She also donated Tip-n-Split products for AMDF to give away to the AMD community as part of awareness raising.

macular.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Non-profit that funds research and provides public education on macular degeneration, glaucoma, and Alzheimer's — directly comparable as a disease-focused research-funding and patient-education non-profit with overlapping AMD mission.

TypeDirect peer
Description

Non-profit funding research to prevent and treat retinal degenerative diseases including AMD and Stargardt disease. Closely comparable mission, donor model, and research-grant approach to AMDF.

TypeDirect peer
Description

Largest volunteer eye health and safety organization in the US; comparable as a non-profit combining patient education, advocacy, and research support across the vision-loss spectrum, including AMD awareness.

TypeRegional player
Description

UK-based charity dedicated exclusively to macular degeneration with research funding, information, and support services — directly comparable mission but serving a different geography than AMDF.

TypeDirect peer
Description

Non-profit that funds eye research at leading US medical institutions and is AMDF's primary research co-funding partner; comparable as a vision-research grantmaker with overlapping research portfolio.

TypeDirect peer
Description

Non-profit funding retinal-disease research, including as a co-funder of the Catalyst Awards with AMDF. Comparable mission and grantmaking model focused on retinal degenerative disease research.

TypeDirect peer
Description

US non-profit providing vision-loss services, advocacy, and behavioral health programs. Comparable as a vision-health non-profit combining patient services and advocacy, though broader than AMD-only.

TypeRegional player
Description

Global umbrella of patient-led retinal disease organizations focused on inherited and age-related retinal conditions including AMD. Comparable mission and advocacy model, but international in scope rather than US-only.

TypeBroad incumbent
Description

Federal government institute conducting and supporting vision research including AMD. Comparable AMD research focus, but operates as a government entity at vastly larger scale and with different funding mechanisms.

TypeBroad incumbent
Description

Non-profit advocating for research on aging-related health issues including vision loss. Comparable as a non-profit funder and advocate for aging-related disease research, though broader than AMD-only.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The American Macular Degeneration Foundation

Vision Health Nonprofitmacular.org

The American Macular Degeneration Foundation is a 501(c)(3) non-profit based in Northampton, MA, that funds AMD research, delivers patient education and awareness resources, and advocates on macular degeneration policy for affected patients, caregivers, and at-risk individuals.

What The American Macular Degeneration Foundation does

The American Macular Degeneration Foundation (AMDF) is a 501(c)(3) publicly supported non-profit (Charity ID #04-3274007) headquartered in Northampton, Massachusetts, dedicated to the prevention, treatment, and cure of macular degeneration. The organization serves people living with age-related macular degeneration in all forms (dry AMD, wet AMD, geographic atrophy) as well as Stargardt disease, alongside caregivers and at-risk individuals. Its core "products" are educational resources (a website, videos, recipes, and the registered Feast for the Eyes® cookbook developed with AMD researcher Dr. Johanna Seddon), awareness assets (the AMD Awareness Pin, the "Losing Sight, Finding Hope" documentary), and research grants funded jointly with Research to Prevent Blindness, the International Retinal Research Foundation, and Fight for Sight — most notably the $300,000-per-grantee RPB/AMDF Catalyst Awards.

AMDF's business model is donation-driven rather than commercial. Revenue is sourced from individual donations (tax-deductible contributions), small-ticket donation products ($25 AMD Awareness Pin, $25 Hope & Cope DVD and quarterly newsletter, $100 Feast for the Eyes Calendar), grassroots fundraising events, and minor-tier corporate partnerships (Bananagrams, Tip-n-Split). The foundation supplements its direct donations by channeling funds through co-funded research grants, effectively leveraging partner foundations' grant-making infrastructure. Its go-to-market is community-led: content marketing via macular.org, YouTube, Facebook, email and print newsletters, plus advocacy campaigns such as the annual "AMDF Goes to Washington" event run jointly with NAEVR to influence federal AMD research funding and Medicare coverage for assistive devices.

The organization operates with a small team of 1–10 employees (described internally as a tight-knit group that shifted to remote work via Zoom during the COVID-19 pandemic) and is led by Founder and President Chip Goehring III, with Matthew Levine as Director of Grants, Partnerships, and Advocacy. AMDF has no parent company, no subsidiaries, and no disclosed revenue figure; it is independent and donor-funded. Recent milestones include the 2023 FDA approval of SYFOVRE — the first geographic atrophy treatment — which AMDF-supported research helped enable, the 2023 dosing of the first patient in Ocugen's gene therapy trial for advanced dry AMD, and ongoing Congressional advocacy for AMD patients through early 2026.

The American Macular Degeneration Foundation firmographics

Firmographics
Name
The American Macular Degeneration Foundation
Legal name
The American Macular Degeneration Foundation
Website
https://macular.org
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
The American Macular Degeneration Foundation is a 501(c)(3) non-profit based in Northampton, MA, that funds AMD research, delivers patient education and awareness resources, and advocates on macular degeneration policy for affected patients, caregivers, and at-risk individuals.
Ownership category
akta.pro rank

The American Macular Degeneration Foundation industry classification

Industry
Product category
Vision Health Nonprofit
NAICS
Religious, Grantmaking, Civic, Professional, and Similar Organizations (813)
akta.pro primary industry
Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

  • Macular degeneration research
  • Vision loss support
  • Retinal disease education
  • Low vision resources
  • Eye health advocacy

Where The American Macular Degeneration Foundation is headquartered

Location

Headquarters

HQ city
Northampton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The American Macular Degeneration Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Contributions: AMDF is a 501(c)(3) non-profit organization funded primarily through donations from individuals. Charity ID #04-3274007. Contributions are tax deductible to the extent allowed by law.
  2. Research Grants and Partnerships: Organization funds research grants through partnerships with other foundations including Research to Prevent Blindness and Fight for Sight, leveraging resources to accelerate AMD research.

Pricing tiers

ModelBillingPrice
OtherOne timeAMD Awareness Pin - available at any donation level
OtherOne timeFeast for the Eyes Calendar - gift with $100+ donation
OtherOne timeHope & Cope DVD and quarterly newsletter

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

The American Macular Degeneration Foundation product offering

Product offering

Core offering

The American Macular Degeneration Foundation (AMDF) is a 501(c)(3) nonprofit organization that funds scientific research into the causes, prevention, and treatment of macular degeneration while providing patient and caregiver education, support resources, and advocacy for those affected by age-related macular degeneration (AMD) and related retinal diseases.

Differentiator

Problem solved

Functional benefit

Brands

  • AMD Awareness Pin: Symbolic awareness pin designed to raise visibility for age-related macular degeneration, featuring eye shapes, orange dots representing AMD as third leading cause of blindness, blue iris for increased risk, starburst center representing central vision loss, and orange petals representing marigold as source of lutein and Zeaxanthin.

Products and services

  • AMD Awareness Pin
  • Feast for the Eyes Calendar
  • Hope & Cope DVD
  • KeepSight Journal
  • Amsler Grid
  • In the Spotlight Newsletter
  • Eat Right for Your Sight Cookbook
  • Losing Sight, Finding Hope Documentary
  • Macular Degeneration Patient Research Registry
  • AMDF Research Grants Program

Quantifiable outcome

  • Funding breakthrough research leading to FDA approval of SYFOVRE, the first treatment for geographic atrophy (advanced dry AMD)
  • +1 more outcomes

Companies that use The American Macular Degeneration Foundation

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

The American Macular Degeneration Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The American Macular Degeneration Foundation partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Research to Prevent Blindness (RPB)coreStrategic or Co-development PartnerAMDF partners with RPB to co-fund the RPB/AMDF Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration. Each grantee receives $300,000 across three years. RPB brings grant-making expertise and broad awareness among leading vision researchers, while AMDF contributes passionate commitment to AMD patients. The partnership more than doubles capacity to fund AMD research.
  • International Retinal Research Foundation (IRRF)coreStrategic or Co-development PartnerIRRF is part of a broader collaboration co-funding AMD research grants alongside RPB and AMDF, supporting a total of four research grants in the Catalyst Awards program.
  • Fight for SightminorStrategic or Co-development PartnerAMDF extended its partnership with Fight for Sight to provide resources for postdoctoral scholars to conduct investigations and travel to the ARVO annual meeting to share concepts with mentors. Grants announced at ARVO.
  • National Alliance for Eye and Vision Research (NAEVR)coreStrategic or Co-development PartnerAMDF works with NAEVR on advocacy efforts including AMDF Goes to Washington events. NAEVR staff including Dan Ignaszewski and Mikyla Bethune joined AMDF in Congressional office visits. Together they co-hosted a Congressional Briefing on macular degeneration.
  • Vision & Art ProjectminorStrategic or Co-development PartnerThe Vision & Art Project is an AMDF-supported project that chronicles the intersection between macular degeneration and the arts. AMDF supports this initiative to inspire and educate about living with vision loss through artistic expression.
  • BananagramsminorGTM or Marketing PartnerBananagrams partnered with AMDF to raise awareness about macular degeneration through the Big Letter Bananagrams game. Proceeds from the game are donated to AMDF, and the companies collaborated on the #BringBigSmiles campaign. AMDF traveled to Rhode Island to help kick off the launch.
  • Tip-n-SplitminorGTM or Marketing PartnerTip-n-Split founder Connie Inukai gives 10% of proceeds from online sales to AMDF. She also donated Tip-n-Split products for AMDF to give away to the AMD community as part of awareness raising.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

The American Macular Degeneration Foundation competitors and assessment

Company assessment

Direct peers

  • BrightFocus Foundation: Non-profit that funds research and provides public education on macular degeneration, glaucoma, and Alzheimer's — directly comparable as a disease-focused research-funding and patient-education non-profit with overlapping AMD mission.
  • Foundation Fighting Blindness: Non-profit funding research to prevent and treat retinal degenerative diseases including AMD and Stargardt disease. Closely comparable mission, donor model, and research-grant approach to AMDF.
  • Prevent Blindness: Largest volunteer eye health and safety organization in the US; comparable as a non-profit combining patient education, advocacy, and research support across the vision-loss spectrum, including AMD awareness.
  • Research to Prevent Blindness: Non-profit that funds eye research at leading US medical institutions and is AMDF's primary research co-funding partner; comparable as a vision-research grantmaker with overlapping research portfolio.
  • International Retinal Research Foundation: Non-profit funding retinal-disease research, including as a co-funder of the Catalyst Awards with AMDF. Comparable mission and grantmaking model focused on retinal degenerative disease research.
  • Lighthouse Guild: US non-profit providing vision-loss services, advocacy, and behavioral health programs. Comparable as a vision-health non-profit combining patient services and advocacy, though broader than AMD-only.

Regional players

  • Macular Society: UK-based charity dedicated exclusively to macular degeneration with research funding, information, and support services — directly comparable mission but serving a different geography than AMDF.
  • Retina International: Global umbrella of patient-led retinal disease organizations focused on inherited and age-related retinal conditions including AMD. Comparable mission and advocacy model, but international in scope rather than US-only.

Broad incumbents

  • National Eye Institute (NEI): Federal government institute conducting and supporting vision research including AMD. Comparable AMD research focus, but operates as a government entity at vastly larger scale and with different funding mechanisms.
  • Alliance for Aging Research: Non-profit advocating for research on aging-related health issues including vision loss. Comparable as a non-profit funder and advocate for aging-related disease research, though broader than AMD-only.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

The American Macular Degeneration Foundation social profiles

Digital presence

The American Macular Degeneration Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The American Macular Degeneration Foundation leadership team

Management profile

Number of profiles

Profiles4 records

The American Macular Degeneration Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The American Macular Degeneration Foundation M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The American Macular Degeneration Foundation

What does The American Macular Degeneration Foundation do?

The American Macular Degeneration Foundation (AMDF) is a 501(c)(3) nonprofit organization that funds scientific research into the causes, prevention, and treatment of macular degeneration while providing patient and caregiver education, support resources, and advocacy for those affected by age-related macular degeneration (AMD) and related retinal diseases.

Is The American Macular Degeneration Foundation a public or private company?

The American Macular Degeneration Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The American Macular Degeneration Foundation founded?

The American Macular Degeneration Foundation was founded in -1. It employs 1 to 10 people.

Where is The American Macular Degeneration Foundation based?

The American Macular Degeneration Foundation is headquartered in Northampton, United States, in the North America region.

How does The American Macular Degeneration Foundation make money?

Two revenue lines are on record. Donations and Contributions are the primary driver. The others are research Grants and Partnerships.

Who are The American Macular Degeneration Foundation's main competitors?

Direct peers on record are BrightFocus Foundation, Foundation Fighting Blindness, Prevent Blindness, Research to Prevent Blindness, International Retinal Research Foundation and Lighthouse Guild. Regional players are Macular Society and Retina International. Broad incumbents are National Eye Institute (NEI) and Alliance for Aging Research.

Does The American Macular Degeneration Foundation have an API?

No public API is recorded for The American Macular Degeneration Foundation.

What industry is The American Macular Degeneration Foundation in?

The American Macular Degeneration Foundation's product category is Vision Health Nonprofit. Its primary akta.pro industry code is BPAIAJAI, Non-Communicable Disease Prevention & Chronic Disease Programs. Its NAICS code is 813.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireLighthouse Guild Receives Grant from American Macular Degeneration Foundation (AMDF)Lighthouse Guild received a $75,000 grant from the American Macular Degeneration Foundation to study assistive technology devices for people with vision impairment. The research aims to provide objective data to help users select devices that best meet their individual needs.GlobeNewswireLighthouse Guild Receives Grant from American Macular Degeneration Foundation (AMDF)Lighthouse Guild has received a $75,000 Thrive Award from the American Macular Degeneration Foundation to evaluate the effectiveness of various assistive technology devices for people with vision impairment. The research aims to provide objective data on device functionality and usability to help patients and providers select appropriate solutions. This initiative leverages Lighthouse Guild's Technology Center to address the growing global need for assistive tech amidst rising rates of age-related vision diseases.PR NewswireNew Website for People Impacted by Age-Related Macular Degeneration Launched by Patient Advocacy GroupsFive patient advocacy organizations—the American Macular Degeneration Foundation, BrightFocus Foundation, MD Support, Prevent Blindness, and The SupportSight Foundation—have launched AMD Central, a new online resource consolidating trusted information and support tools for patients and caregivers affected by age-related macular degeneration. The website features accessibility options including adjustable display settings, audio and print materials, and Spanish-language content to help users manage their eye condition and health wellness. The creation of AMD Central was made possible through support from Novartis Pharmaceuticals Corporation.PR NewswireAMDF Grantee Dr. Johanna Seddon Receives Prestigious Eye Research AwardDr. Johanna Seddon from Tufts University School of Medicine received the 2017 Mildred Weisenfeld Award for Excellence in Ophthalmology at the ARVO annual meeting for her significant contributions to the field of age-related macular degeneration (AMD). She is recognized for her research on risk factors for AMD, including genetic variants and lifestyle factors that can influence the disease. The American Macular Degeneration Foundation (AMDF) has supported her work, enhancing its application to lifestyle choices for patients.